
Coeptis Therapeutics: Developing and acquiring pharmaceutical products through strategic partnerships.
Coeptis Therapeutics, a biopharmaceutical company, was founded with the mission to improve outcomes for cancer patients through innovative cell therapy platforms. The company focuses on the development and acquisition of pharmaceutical products, leveraging strategic partnerships with multiple pharmaceutical companies to evolve its product pipeline. Coeptis Therapeutics aims to bring advanced therapeutic solutions to the oncology market, addressing unmet medical needs in cancer treatment.
Notable figures affiliated with Coeptis Therapeutics include key scientists and industry experts who drive the company's research and development efforts. The company has garnered attention from investors interested in cutting-edge cancer therapies. Among its key achievements are the successful establishment of strategic partnerships and the development of promising cell therapy platforms. Coeptis Therapeutics is making a significant impact in the biopharmaceutical industry by advancing innovative treatments that have the potential to transform cancer care.

Coeptis Pharmaceuticals

Vinings Holdings

Zenopharm

Coherus BioSciences
coherus.com

Tigris Pharmaceuticals
tigrispharma.com

Signet Therapeutics

Checkpoint Therapeutics
checkpointtx.com

Celltheon
celltheon.com

XTuit Pharmaceuticals

Spheringenics

Partner Therapeutics
partnertx.com

Duet BioTherapeutics

PanTher Therapeutics
panthertx.com

PleoPharma
pleopharma.com

Cello Therapeutics
cellothera.com
Companies similar to Z Squared include Coeptis Pharmaceuticals, Vinings Holdings, Zenopharm and Coherus BioSciences.
Z Squared was founded in 1996.
Z Squared's headquarters is located in Wexford, PA, US.
Z Squared's most recent funding round was for $2M (USD) in October 2023.
As of Oct 24, 2023, Z Squared has raised a total of $11M (USD).
Z Squared has 10 employees as of Feb 5, 2024.